Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders

NCT00992459 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Urea Cycle Disorders

Interventions

DRUG: HPN-100
DRUG: Buphenyl (NaPBA)

Sponsor

Amgen